Breaking the Age Barrier: Mucinous Adenocarcinoma of the Bladder in a Young Man
Keywords:
Invasive Bladder adenocarcinoma, haematuria, immunohistochemistryAbstract
Adenocarcinoma is a rare form of malignancy, representing approximately 0.5% to 2% of all bladder cancers. Approximately 90% of patients exhibit haematuria at presentation. The condition primarily affects adults, peaking in incidence during the seventh decade of life, with a higher occurrence in males. Tumors can develop throughout the urinary tract, including the bladder, urethra, renal pelvis and ureter. Due to its rarity, the underlying causes are not well understood. It has been postulated that bladder adenocarcinoma may result from malignant transformation of intestinal metaplasia in the urothelial mucosa. In our study we have diagnosed, A 24 year old male patient from West Bengal, who presented with tumor sized 3.8x3.5x3.5cm in the dome of bladder was diagnosed with primary invasive adenocarcinoma of bladder – mucinous type. The diagnostic challenge of this case that we had to thoroughly evaluate to exclude the primary from other organs like colon or prostrate. Mucinous and signet-ring cell histological patterns are extremely rare, and they are often challenging to differentiate morphologically from metastatic colorectal adenocarcinoma. Careful correlation with clinical, radiological, biopsy, staging and immunohistochemistry plays a vital role in diagnosing such rare tumor. Stage is important prognostic factor. 5 year disease free survival rate is 40-50%. Treatment is radical cystectomy followed by adjuvant therapy with chemo or radiotherapy, after excluding gastrointestinal origin primary malignancy
Downloads
References
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer.
Sigalas K, Tyritzis SI, Trigka E, Katafigiotis I, Kavantzas N, Stravodimos KG. A male presenting with a primary mucinous bladder carcinoma: a case report. Cases J. 2010 Feb 3;3:49. doi: 10.1186/1757-1626-3-49. PMID: 20205820; PMCID: PMC2824640.
Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol. 2012 Nov 2;7: 151.
Amin MB, editor. WHO classification of tumours: Urinary and male genital tumours. International Agency for Research on Cancer; 2022.
Zaghloul MS, Nouh A, Nazmy M, et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 2006;24:13-20.
Marques ML, D’Alessandro GS, Chade DC, Lanzoni VP, Saiovici S, Ramos de Almeida JR: Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J. 2007;125:297-99.
Marques ML, D'Alessandro GS, Chade DC, Lanzoni VP, Saiovici S, Almeida CJ. Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J. 2007 Sep 6;125(5):297-9. doi: 10.1590/s1516-31802007000500011. PMID: 18094900; PMCID: PMC11041510.
Zhang BY, Aguilar J, Yang M, et al. Mucinous metaplasia in urothelial tract may be the precancerous lesion of mucinous adenocarcinoma: report of two cases and review of literature. Int J Clin Exp Med 2014;7:285-9.
Wang D, Zhang K, Guan L, Wen N. Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review. Transl Cancer Res. 2022 Jul;11(7):2416-2424. doi: 10.21037/tcr-22-1547. PMID: 35966298; PMCID: PMC9372207.
Ghewade P, Shukla S, Vagha S, Kalode SS, Gadkari P. Primary Adenocarcinoma of the Urinary Bladder: A Case Report on a Rare Malignancy. Cureus. 2024 Aug 6;16(8):e66269. doi: 10.7759/cureus.66269. PMID: 39238745; PMCID: PMC11375912.
Singh I, Prasad R. Primary urachal mucinous adenocarcinoma of the urinary bladder. J Clin Diagn Res. 2013 May;7(5):911-3. doi: 10.7860/JCDR/2013/5597.2973. Epub 2013 May 1. PMID: 23814741; PMCID: PMC3681068.
Chang SS, Bochner BH, Chou R, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 2017;198:552-9.
Merseburger AS, Apolo AB, Chowdhury S, et al. SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. World J Urol 2019;37:95-105.
Vijayakumar V, Natesan G, Sudhakar M, Prakasam U, Seeralan V, Kaliyaperumal M et al. Primary Mucinous Adenocarcinoma of the Bladder: Case Report and Review of Literature. Indian J Surg Oncol. 2020 Sep;11(Suppl 1): 44-7.
Melicow MM. Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol. 1955 Oct;74(4): 498-521.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.